Panacea provides AI-native FDA regulatory services for biotech and medical device companies. The firm pairs experienced FDA consultants with an AI platform to accelerate the path to FDA approval while lowering cost, using fixed milestone-based pricing rather than hourly billing. It supports all FDA regulatory pathways including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, and BDD. Panacea was founded by Haris Javed-Akhtar and Yaman Ziadeh, both previously at Anterior, and is part of Y Combinator's Spring 2026 batch.
Panacea
ActiveAI-Native FDA Regulatory Services
Total raised
$500K
1 round
Stage
Seed
Jan 2026
Team
1-10
since 2026
Pricing
—
Founded
2026
San Francisco, United States
Agent-ready
—
AI-native FDA regulatory services for biotech and medical devices
Pairs experienced FDA consultants with an AI platform
Fixed milestone-based pricing instead of hourly billing
Support for all FDA regulatory pathways
Coverage of IND, NDA, BLA, ODD, and Pre-Subs submissions
Coverage of 510(k), De Novo, PMA, IDE, and BDD pathways
AI-assisted acceleration of the path to approval
Human expert oversight throughout the process
12/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
Jan 2026 Seed $500K ● Y Combinator
Capital network
$500K raised ·1 backer·10 network links
- Backers1
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Pearl Health
AI value-based care platform for primary care providers
AI AnalyticsAI Healthcare
Commure
AI Healthcare
Innovaccer
AI Healthcare
Truveta
AI Healthcare
Terray Therapeutics
Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery
AI HealthcareDrug Discovery
Genesis Molecular AI
Generative AI for small-molecule drug discovery
AI HealthcareDrug Discovery
- What does Panacea offer?
- Panacea provides AI-native FDA regulatory services, pairing experienced FDA consultants with an AI platform to accelerate and de-risk the path to FDA approval for biotech and medical device companies.
- How does Panacea price its services?
- It uses fixed milestone-based pricing rather than hourly billing, offering more cost predictability for clients.
- Which FDA pathways does it support?
- It supports all FDA regulatory pathways, including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, and BDD.
- Who founded Panacea?
- It was founded by Haris Javed-Akhtar and Yaman Ziadeh, both previously at Anterior, and is part of Y Combinator's Spring 2026 batch. It is San Francisco-based.
Discussion
Sign in to join the discussion.
Sign inExplore more around Panacea
Contextual paths to related AI startups, deals and rankings.